The amino acid substitutions Ser288Gly and Val320Ala convert the cortisol producing enzyme, CYP11B1, into an aldosterone producing enzyme
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Transfection studies with cDNAs encoding hybrids between the highly similar cytochrome P450 enzymes, CYP11B1 (steroid 11 beta-hydroxylase) and CYP11B2 (aldosterone synthase) have identified which amino acids determine the different activities of the enzymes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in vitro suggest that changing Ser288 and Val320 would suffice (497), and artificial activating mutations that increase the aldosterone synthase activity of P450c11AS have been created in vitro (498).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [497]
In the citing paper
“Residues 288, 296, 301, 302, 325, and, perhaps most importantly, 320 are critical (496, 497).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [497]
Citations
Cites
NELSON, D. R., KAMATAKI, T., WAXMAN, D. J., GUENGERICH, F. P., ESTABROOK, R. W., FEYEREISEN, R., GONZALEZ, F. J., COON, M. J., GUNSALUS, I. C., GOTOH, O., et al. (1993) · DNA and Cell Biology · doi:10.1089/dna.1993.12.1 · Cited by 1,655
High-resolution crystal structure of cytochrome P450cam
Poulos, T. L., Finzel, B. C., & Howard, A. J. (1987) · Journal of Molecular Biology · doi:10.1016/0022-2836(87)90190-2 · Cited by 1,411
Lifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Cook, S., Ulick, S., & Lalouel, J.-M. (1992) · Nature · doi:10.1038/355262a0 · Cited by 1,158
Crystal Structure of Hemoprotein Domain of P450BM-3, a Prototype for Microsomal P450's
Ravichandran, K. G., Boddupalli, S. S., Hasermann, C. A., Peterson, J. A., & Deisenhofer, J. (1993) · Science · doi:10.1126/science.8342039 · Cited by 877
Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta).
Mornet, É., Dupont, J., Vitek, A., & White, P. C. (1989) · PubMed · Cited by 440
Characterization of Two Genes Encoding Human Steroid 11β-Hydroxylase (P-45011β)
Mornet, E., Dupont, J., Vitek, A., & White, P. C. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)30030-4 · Cited by 405
Crystal structure and refinement of cytochrome P450terp at 2·3 Å resolution
Hasemann, C. A., Ravichandran, K. G., Peterson, J. A., & Deisenhofer, J. (1994) · Journal of Molecular Biology · doi:10.1016/0022-2836(94)90019-1 · Cited by 394
Structure of cytochrome P450eryF involved in erythromycin biosynthesis
Cupp-Vickery, J. R., & Poulos, T. L. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb0295-144 · Cited by 371
The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex
Curnow, K. M., Tusie-Luna, M.-T., Pascoe, L., Natarajan, R., Gu, J.-L., Nadler, J. L., & White, P. C. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-10-1513 · Cited by 362
Self-citationLifton, R. P., Dluhy, R. G., Powers, M., Rich, G. M., Gutkin, M., Fallo, F., Gill, J. R., Feld, L., Ganguly, A., Laidlaw, J. C., et al. (1992) · Nature Genetics · doi:10.1038/ng0992-66 · Cited by 336
Research works printed but not linked: 2
- 10.1210/jc.81.1.321 · doi:10.1210/jc.81.1.321 · Paper page
- Nonaka Y., 1995, Eur. J. Biochem., 229, 249, 10.1111/j.1432-1033.1995.tb20462.x · doi:10.1111/j.1432-1033.1995.tb20462.x · Paper page
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Human cytochromes P450 in health and disease
Nebert, D. W., Wikvall, K., & Miller, W. L. (2013) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2012.0431 · Cited by 505
“Residues 288, 296, 301, 302, 320 and 325 are critical [130,131]; these residues lie in or near the I-helix, and are expected to alter activesite geometry.”
BackgroundFardella, C. E., Mosso, L., Gómez-Sánchez, C., Cortés, P., Soto, J., Gómez, L., Pinto, M., Huete, A., Oestreicher, E., Foradori, A., et al. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.5.6596 · Cited by 463
Adrenal vein sampling in primary aldosteronism: towards a standardised protocol
Monticone, S., Viola, A., Rossato, D., Veglio, F., Reincke, M., Gomez-Sanchez, C., & Mulatero, P. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70069-5 · Cited by 181
Self-citationStructural Insights into Aldosterone Synthase Substrate Specificity and Targeted Inhibition
Strushkevich, N., Gilep, A. A., Shen, L., Arrowsmith, C. H., Edwards, A. M., Usanov, S. A., & Park, H.-W. (2013) · Molecular Endocrinology · doi:10.1210/me.2012-1287 · Cited by 135
Mulatero, P., di Cella, S. M., Monticone, S., Schiavone, D., Manzo, M., Mengozzi, G., Rabbia, F., Terzolo, M., Gomez-Sanchez, E. P., Gomez-Sanchez, C. E., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2384 · Cited by 133
“18-Hydroxycorticosterone (18OHB) is an intermediate precursor in aldosterone biosynthesis with low affinity for the MR that originates from the conversion of corticosterone by the aldosterone synthase (7), although small amounts may be produced by the 11 -hydroxylase (8).”
BackgroundSelf-citationMulatero, P., Veglio, F., Pilon, C., Rabbia, F., Zocchi, C., Limone, P. P., Boscaro, M., Sonino, N., & Fallo, F. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2573 · Cited by 126
“gene conversions or point mutation, undetectable by long PCR or Southern blotting techniques may be the cause of a different genetic type of GRA (22, 23).”
BackgroundSelf-citationModulation of aldosterone and cortisol synthesis on the molecular level
Lisurek, M., & Bernhardt, R. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.11.008 · Cited by 116
Stowasser, M., & Gordon, R. D. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00097-8 · Cited by 101
Mulatero, P., Curnow, K. M., Aupetit-Faisant, B., Foekling, M., Gomez-Sanchez, C., Veglio, F., Jeunemaitre, X., Corvol, P., & Pascoe, L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5237 · Cited by 88
Self-citationThe Human Steroid Hydroxylases CYP11B1 and CYP11B2
Bureik, M., Lisurek, M., & Bernhardt, R. (2002) · Biological Chemistry · doi:10.1515/bc.2002.174 · Cited by 87
“(Bottner and Bernhardt, 1996) or in combination with positions 288 (Ser to Gly) (Curnow et al., 1997) or 335 (Asn to Asp) (Bottner et al.”
BackgroundInfluentialGeneral overview of mineralocorticoid hormone action
Agarwal, M. K., & Mirshahi, M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00038-8 · Cited by 99
Glucocorticoid-remediable aldosteronism
Dluhy, R. G., & Lifton, R. P. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6256 · Cited by 74
Schiffer, L., Brixius‐Anderko, S., Hannemann, F., Eiden-Plach, A., & Bernhardt, R. (2014) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2014.10.011 · Cited by 84
Lucas, S., Negri, M., Heim, R., Zimmer, C., & Hartmann, R. W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101470k · Cited by 75
Primary aldosteronism: learning from the study of familial varieties
Stowasser, M., & Gordon, R. D. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018090-00002 · Cited by 72
Mulatero, P., di Cella, S. M., Williams, T. A., Milan, A., Mengozzi, G., Chiandussi, L., Gómez-Sánchez, C. E., & Veglio, F. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.7.3187 · Cited by 73
Self-citationEnberg, U., Volpe, C., Höög, A., Wedell, A., Farnebo, L.-O., Thoren, M., & Hamberger, B. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510073 · Cited by 71
“Theoretically, the CYP11B1 protein may acquire the capacity to produce aldosterone by mutation to CYP11B2-like sequences in regions encoded by exons 5 and 6 ( 25 ).”
BackgroundDisorders of the Aldosterone Synthase and Steroid 11β-Hydroxylase Deficiencies
Peter, M., Dubuis, J.-M., & Sippell, W. G. (1999) · Hormone Research in Paediatrics · doi:10.1159/000023374 · Cited by 62
“raises the question as to whether other enzymes, also involved in mineralocorticoid biosynthesis in humans, may be defective in this disorder.The homologous P450 enzymes aldosterone synthase and 11β-hydroxylase differ in 35 amino acids. Amino acid residues have been identified in a recent study using transfection expe…”
BackgroundHampf, M., Dao, N. T. N., Hoan, N. T., & Bernhardt, R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7820 · Cited by 56
Modelling of three-dimensional structures of cytochromes P450 11B1 and 11B2
Belkina, N. V., Lisurek, M., Ivanov, A. S., & Bernhardt, R. (2001) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(01)00331-2 · Cited by 64
New Perspectives On The Role Of Aldosterone Excess In Cardiovascular Disease
Stowasser, M. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03523.x · Cited by 58
Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism
Fallo, F., Pilon, C., Williams, T. A., Sonino, N., di Cella, S. M., Veglio, F., Iasio, R. D., Montanari, P., & Mulatero, P. (2003) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1001636 · Cited by 60
Self-citationSocorro, S., Martins, R. S. T., Deloffre, L. A. M., Mylonas, C. C., & Canário, A. V. M. (2006) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2006.07.018 · Cited by 57
“Amino acids G288 and A320 of human CYP11B2, which are necessary for strong aldosterone synthase activity (Curnow et al., 1997; Mulatero et al., 1998), are simulta- neously conserved in all CYP11B sequences known to have aldosterone synthase activity.”
BackgroundGENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism
Monticone, S., Buffolo, F., Tetti, M., Veglio, F., Pasini, B., & Mulatero, P. (2018) · European Journal of Endocrinology · doi:10.1530/eje-17-0946 · Cited by 60
Self-citationMa, H., & Penning, T. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11161 · Cited by 52
The Adrenal Cortex and its Disorders
Miller, W. L. (2009) · Brook's Clinical Pediatric Endocrinology · doi:10.1002/9781444316728.ch13 · Cited by 50
Familial hyperaldosteronism type III
Monticone, S., Tetti, M., Burrello, J., Buffolo, F., Giovanni, R. D., Veglio, F., Williams, T. A., & Mulatero, P. (2017) · Journal of Human Hypertension · doi:10.1038/jhh.2017.34 · Cited by 53
Self-citationBrixius‐Anderko, S., & Scott, E. E. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006214 · Cited by 53
“Notably, the identity of residue 320 immediately following this nonhelical region is crucial for the 18-oxidase function of CYP11B2 (25) and may be important in differential binding and orientation of the respective substrates.”
BackgroundPortrat, S., Mulatero, P., Curnow, K. M., Chaussain, J.-L., Morel, Y., & Pascoe, L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.7.7671 · Cited by 46
“It has been shown that amino acid residues encoded in exons 5 and 6 of CYP11B2 are particularly important to these additional activities (17, 18).”
BackgroundSelf-citationFardella, C., Pinto, M. P., Mosso, L. M., Gómez-Sánchez, C. E., Jalil, J., & Montero, J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.10.7920 · Cited by 46
Connell, J., Fraser, R., MacKenzie, S. M., Friel, E. C., Ingram, M. C., Holloway, C. D., & Davies, E. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.025 · Cited by 45
Hakki, T., Zearo, S., Drăgan, C.-A., Bureik, M., & Bernhardt, R. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.06.022 · Cited by 45
Hereditary Defect in Biosynthesis of Aldosterone: Aldosterone Synthase Deficiency 1964–19971
Peter, M., Fawaz, L., Drop, S. L. S., Visser, H. K. A., & Sippell, W. G. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4399 · Cited by 40
“tion requires a glycine residue at position 288, and subsequent sufficient 18-oxidation requires an alanine at position 320 (24).”
BackgroundPrimary aldosteronism: Rare bird or common cause of secondary hypertension?
Stowasser, M. (2001) · Current Hypertension Reports · doi:10.1007/s11906-001-0045-3 · Cited by 41
“These workers could also find no evidence in these patients of mutations within the 11βhydroxylase gene (CYP11B1), which have been shown in vitro to confer aldosterone synthase activity to its gene product [ 51 ], and could theoretically result in adrenocorticotropic hormone-regulated aldosterone overproduction in viv…”
BackgroundTubular Disorders of Electrolyte Regulation
Devuyst, O., Konrad, M., Jeunemaître, X., & Zennaro, M. (2009) · Springer eBooks · doi:10.1007/978-3-540-76341-3_38 · Cited by 36
Genetics of primary aldosteronism
Mulatero, P., Morello, F., & Veglio, F. (2004) · Journal of Hypertension · doi:10.1097/00004872-200404000-00001 · Cited by 36
Self-citationReddish, M. J., & Guengerich, F. P. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009830 · Cited by 33
Peter, M., Bünger, K., Drop, S., & Sippell, W. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390096 · Cited by 34
Zhao, L.-Q., Su, H., & Tian, H. (2008) · World Journal of Pediatrics · doi:10.1007/s12519-008-0016-8 · Cited by 32
The Adrenal Cortex and Its Disorders
Miller, W. L., Achermann, J. C., & Flück, C. E. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50017-x · Cited by 33
Pilon, C., Mulatero, P., Barzon, L., Veglio, F., Garrone, C., Boscaro, M., Sonino, N., & Fallo, F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.11.6125 · Cited by 30
Self-citationFamilial or Genetic Primary Aldosteronism and Gordon Syndrome
Stowasser, M., Pimenta, E., & Gordon, R. D. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.007 · Cited by 26
Peng, H., & Auchus, R. J. (2017) · Biochemistry · doi:10.1021/acs.biochem.7b00034 · Cited by 26
Mutation THR-185 ILE is associated with corticosterone methyl oxidase deficiency type II
Peter, M., Bünger, K., Sólyom, J., & Sippell, W. G. (1998) · European Journal of Pediatrics · doi:10.1007/s004310050833 · Cited by 27
Bechtel, S., Belkina, N., & Bernhardt, R. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.02729.x · Cited by 30
Jenkins, L. M. M., Durell, S. R., Maynard, A. T., Stahl, S. J., Inman, J. K., Appella, E., Legault, P., & Omichinski, J. G. (2006) · Journal of the American Chemical Society · doi:10.1021/ja063329e · Cited by 30
Vecchiola, A., Lagos, C. F., Fuentes, C., Allende, F. A., Campino, C., Valdivia, C. P., Tapia-Castillo, A., Ogishima, T., Mukai, K., Owen, G. I., et al. (2013) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-11-76 · Cited by 23
“Interestingly, a feature of ASCE is that it contains all of the substitutions reported to convert CYP11B1 into an aldosterone synthase enzyme, such as S288G, V320A and N335D [12,44].”
BackgroundA Compound Heterozygote Case of Type II Aldosterone Synthase Deficiency
Dunlop, F., Crock, P., Montalto, J., Funder, J. W., & Curnow, K. M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030353 · Cited by 26
Self-citationMonogenic mineralocorticoid hypertension
Stowasser, M., & Gordon, R. D. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.008 · Cited by 22
New Insights in the Functional Zonation of the Canine Adrenal Cortex
Sanders, K., Mol, J. A., Kooistra, H. S., Slob, A., & Galac, S. (2016) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.13946 · Cited by 25
“Curnow et al.31 state that the amino acid sequence of a CYP11B protein can predict whether the enzyme has an aldosterone synthase activity.”
BackgroundDisorders of mineralocorticoid synthesis
Connell, J., Fraser, R., & Davies, E. (2001) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1053/beem.2000.0118 · Cited by 22
Kuribayashi, I., Nomoto, S., Massa, G., Oostdijk, W., Wit, J. M., Wolffenbuttel, B. H. R., Shizuta, Y., & Honke, K. (2005) · Hormone Research in Paediatrics · doi:10.1159/000087074 · Cited by 28
“The current chimeric CYP11B2/CYP11B1 protein showed 11β-hydroxylase activity, but not 18-hydroxylase/oxidase activities. It has been demonstrated that p.S288G and p.V320A could change 11β-hydroxylase into aldosterone synthase [”
BackgroundAldosterone SecretionA Molecular Perspective
Boon, W. C., Coghlan, J. P., Curnow, K. M., & McDougall, J. G. (1997) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(97)00136-7 · Cited by 24
Self-citationFisher, A., Fraser, R., Connell, J., & Davies, E. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.3.6470 · Cited by 22
“The use of B and 18-OH-B as substrates would provide a clearer picture of the effects of CYP11B2-D147E on 18-modifying functions of the enzyme, but these make poor substrates for aldosterone synthase (23), and the affinities of the enzymes for these substrates were not determined by ourselves or others (6, 7).”
BackgroundInfluentialEzquieta, B., & Luzuriaga, C. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00291.x · Cited by 22
“These amino acids at CYP11B2 Gly 288 (GGC) and Ala 320 (GCG) are described as important for aldosterone synthase activity (9, 10, 24) and their substitution as compatible with CYP11B2 deficiency.”
BackgroundDiagnosis of Glucocorticoid-Remediable Aldosteronism in Hypertensive Children
Kamrath, C., Maser‐Gluth, C., Haag, C., & Schulze, E. (2011) · Hormone Research in Paediatrics · doi:10.1159/000326524 · Cited by 18
Functional and expression analysis of ovine steroid 11ß-hydroxylase (Cytochrome P45011ß)
Boon, W. C., Roche, P. J., Butkus, A., McDougall, J. G., Jeyaseelan, K., & Coghlan, J. P. (1997) · Endocrine Research · doi:10.1080/07435809709031861 · Cited by 17
Species differences in 3-methylsulphonyl-DDE bioactivation by adrenocortical tissue
Lindström, V., Brandt, I., & Lindhe, Ö. (2007) · Archives of Toxicology · doi:10.1007/s00204-007-0264-8 · Cited by 15
“Small mutations of amino acids in the substrate-binding region seem to be of crucial importance for the 11 -hydroxylase activity of the CYP11B1 protein regarding endogenous substrates (Böttner et al. 1996, 1998; Curnow et al. 1997).”
BackgroundGenetic Studies in Familial Aldosteronism Not Suppressible by Dexamethasone
Fallo, F., Veglio, F., Mulatero, P., Sonino, N., Pilon, C., Barzon, L., Trimarchi, F., Boscaro, M., & Benvenga, S. (2000) · International Journal on Disability and Human Development · doi:10.1515/ijdhd.2000.1.3.159 · Cited by 16
Self-citationGuo, C., Zhang, G., Wu, C., Yi, L., Wang, Y., & Yang, J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116521 · Cited by 15
Genetic disorders in primary aldosteronism—familial and somatic
Funder, J. W. (2016) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2016.03.020 · Cited by 16
Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production
Nicod, J., Dick, B., Frey, F. J., & Ferrari, P. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2003.10.056 · Cited by 15
Effects of genetic variation in the aldosterone synthase (CYP11B2) gene on enzyme function
Holloway, C. D., MacKenzie, S. M., Fräser, R., Miller, S., Barr, M., Wilkinson, D. M., Forbes, G., Friel, E. C., Connell, J., & Davies, E. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03383.x · Cited by 12
A Particular Phenotype in a Girl with Aldosterone Synthase Deficiency
Williams, T. A., Mulatero, P., Bosio, M., Lewicka, S., Palermo, M., Veglio, F., & Armanini, D. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031912 · Cited by 17
“Thus, both alleles of CYP11B2 of the patient carry mutations encoding premature stop codons that are located before critical active site residues of the aldosterone synthase enzyme encoded by CYP11B2 (21).”
BackgroundSelf-citationLATE STEPS OF ALDOSTERONE BIOSYNTHESIS: SHEEP ARE NOT RATS
Boon, W. C., Coghlan, J. P., & McDougall, J. G. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02296.x · Cited by 10
Renal Tubular Disorders of Electrolyte Regulation in Children
Devuyst, O., Belge, H., Konrad, M., Jeunemaître, X., & Zennaro, M. (2015) · Springer eBooks · doi:10.1007/978-3-662-43596-0_34 · Cited by 10
Glucocorticoid-Remediable Aldosteronism
Dluhy, R. G. (2001) · The Endocrinologist · doi:10.1097/00019616-200107000-00003 · Cited by 7
Mulatero, P., Glorioso, N., Fallo, F., Soro, A., di Cella, S. M., Carra, R., Filigheddu, F., & Veglio, F. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1440397 · Cited by 7
“Single amino acids are responsible for the additional activities in position C18 displayed by aldosterone synthase: Gly288 confers the 18-hydroxylase activity to the enzyme and Ala320 confers 18oxidase activity ( 5 , 6). Therefore, single amino acid substitutions can determine important changes in the enzyme activity.”
BackgroundSelf-citationRenal tubular disorders of electrolyte regulation in children
Devuyst, O., Belge, H., Konrad, M., Jeunemaître, X., & Zennaro, M. (2016) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-121793 · Cited by 8
“This recombination takes place always upstream of exon 5, since this exon contains two residues that differ between the two homologous enzymes [365] and that are critical to confer the aldosterone synthase specificity.”
BackgroundFisher, A., Davies, E., Fraser, R., & Connell, J. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02299.x · Cited by 9
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00096-4 · Cited by 6
Mukai, K., Sugimoto, H., Kamiya, K., Suzuki, R., Matsuura, T., Hishiki, T., Shimada, H., Shiro, Y., Suematsu, M., & Kagawa, N. (2021) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2021.08.001 · Cited by 4
“(iv) CYP11B1 S288G/V320A gains aldosterone synthase activity as well as 11β,18-dihydroxylase activity that are comparable to those of wild type CYP11B2 (Curnow et al., 1997).”
BackgroundInfluentialGenetic Forms of Primary Aldosteronism
Stowasser, M., Fallo, F., So, A., Jeske, Y. W. A., Kelemen, L., Pilon, C., & Gordon, R. D. (2007) · High Blood Pressure & Cardiovascular Prevention · doi:10.2165/00151642-200714020-00004 · Cited by 4
Deficiência da 11beta-hidroxilase
de Mello, M. P., Penachioni, J. Y., do Amaral, F. C., & de Castro, M. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000500018 · Cited by 7
Aldosterone as an Independent Factor in Cerebrovascular Damage
Mulatero, P., Caserta, M., Bertello, C., Schiavone, D., Verhovez, A., Giraudo, G., Morello, F., & Veglio, F. (2008) · Clinical and Experimental Hypertension · doi:10.1080/10641960802566017 · Cited by 4
“The breakpoint of the hybrid gene occurs between intron 2 and exon 4; in fact, a crossover occurring at the 3’-end of the codon for amino acid 288 in exon 5 would give rise to a gene encoding an enzyme unable to perform aldosterone synthesis (74).”
BackgroundSelf-citationNonaka, Y., Fujii, T., Bernhardt, R., & Okamoto, M. (1998) · Endocrine Research · doi:10.3109/07435809809032656 · Cited by 4
Lindhe, Ö. (2001) · DiVA (Digitala Vetenskapliga Arkivet) · Cited by 5
Chen, X., Li, Q., Huang, L., & Wu, P. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70062 · Cited by 3
The Principles, Enzymes, and Pathways of Human Steroidogenesis
Auchus, R. J., & Miller, W. L. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-18907-1.00097-4 · Cited by 3
Familial Hyperaldosteronism Type II
Stowasser, M., & Gordon, R. D. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_7 · Cited by 2
Structures of Mitochondrial P450 System Proteins
Hanukoglu, I. (1999) · Springer eBooks · doi:10.1007/978-1-4615-4855-3_3 · Cited by 2
Chimeric Genes Causing 11β-Hydroxylase Deficiency: Implications in Clinical and Molecular Diagnosis
Concolino, P. (2024) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-024-00697-y · Cited by 2
“…shown that only two (positions 288 in exon 5 and 320 in exon 6) of the 35 amino acids differences distinguishing the CYP11B1 and CYP11B2 enzymes are responsible for the additional 18-hydroxylase and 18-oxidase activities possessed by CYP11B2, but not CYP11B1, when DOC is used as the substrate [31].”
Primary Aldosteronism: Progress in Diagnosis, Therapy, and Genetics
Mulatero, P., Williams, T. A., Monticone, S., Viola, A., Tizzani, D., Crudo, V. L., Burrello, J., & Veglio, F. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-548-4_1 · Cited by 1
Self-citationPecori, A., Monticone, S., Losano, I., Cavaglià, G., Pieroni, J., Veglio, F., & Mulatero, P. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-45562-0_5 · Cited by 1
Self-citationMenassa, R. (2009) · theses.fr (ABES) · doi:10.70675/b3e39fd0z238az4865z8447z7bdf24b846fb · Cited by 1
Genetics of Familial Hyperaldosteronism
Monticone, S., Tetti, M., Losano, I., Veglio, F., & Mulatero, P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64319-2 · Cited by 1
Self-citationThe Adrenal Cortex and its Disorders
Miller, W. L. (2005) · Wiley eBooks · doi:10.1002/9780470987117.ch15 · Cited by 4
Genetica dell'iperaldosteronismo primitivo
Spoto, B., Gervasi, A., Bresolin, G., & Zoccali, C. (2004)
Mineralocorticoid Biosynthetic Pathways and Hypertension
Gómez-Sánchez, C. E. (1998) · Endocrine updates · doi:10.1007/978-1-4615-5569-8_16
Molekulare Grundlagen von Erkrankungen der Nebenniere
Reincke, M., Peter, M., Neumann, H. P. H., Bender, B., & Gimm, O. (2001) · Springer eBooks · doi:10.1007/978-3-642-56858-9_10
Alvarez‐Madrazo, S. (2010) · Enlighten: Theses (The University of Glasgow)
Molecular genetics in childhood hypertension
Morris, B. J. (1998) · Progress in Pediatric Cardiology · doi:10.1016/s1058-9813(99)00007-7 · Cited by 1
Steroid 11β-Hydroxylase Deficiency
White, P. C. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-101-5_20
Genetics of Blood Pressure Regulation
Ong, F. S.-C., Bernstein, K. E., & Rotter, J. I. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00058-6
Renal Tubular Disorders of Electrolyte Regulation in Children
Devuyst, O., Belge, H., Konrad, M., Jeunemaître, X., & Zennaro, M. (2015) · Springer eBooks · doi:10.1007/978-3-642-27843-3_34-1 · Cited by 2
Familial Hyperaldosteronism Type I
Mulatero, P., Monticone, S., Veglio, F., & Williams, T. A. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0509-6_6
Self-citationGenetics of familial hyperaldosteronism
Monticone, S., Dodaro, V., & Mulatero, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00137-0
Self-citationAldosterone Synthase Deficiency
Peter, M., & Sippell, W. G. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-101-5_26
Metadata
- Authors
- Curnow, K. M., Mulatero, P., Emeric-Blanchouin, N., Aupetit-Faisant, B., Corvol, P., & Pascoe, L.
- Affiliations
- Inserm (FR)
- ORCID
- Mulatero, Paolo
- Venue
- Nature Structural & Molecular Biology
- Published
- 1997-01
- Volume
- 4
- Issue
- 1
- Pages
- 32-35
- ISSN
- 1545-9985 (ISSN-L)
- 1545-9993
- OpenAlex
- W2038951667
- Semantic Scholar
- 45473135d8818aba73d5523459e4b6fb39bc305f
- Cited by
- 102
- References
- 28
- Citations by year
- 2025: 1 · 2024: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 4 · 2013: 4 · 2012: 2
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Structural & Molecular Biology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
- Keywords
- CYP11B1, CYP11B2, steroid 11beta-hydroxylase, aldosterone synthase, cytochrome P450, amino acid substitutions, hybrid enzymes, transfection, steroidogenesis
- MeSH terms
- Aldosterone, Amino Acid Sequence, Amino Acids, Humans, Hydrocortisone, Mitochondria, Molecular Sequence Data, Steroid 11-beta-Hydroxylase, Transfection, Sequence Homology, Amino Acid, Protein Structure, Tertiary, DNA, Complementary
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.